We have previously developed the succinylated poly(glycidol)-modified liposome which becomes fusigenic under weakly acidic condition. In this report, we describe that complexation of this pH-sensitive, fusigenic liposome with a lipoplex consisting of 3␤-(N-(NЈ,NЈ-dimethylaminoethane) carbamoyl)cholesterol, dioleoylphosphatidylethanolamine and plasmid DNA gives efficient gene delivery systems. In this study, we prepared the complexes, which are termed SucPG-complexes, with a positively or negatively charged surface by mixing the lipoplex with varying amounts of the SucPG-modified liposomes. The positively charged SucPGcomplexes either bearing or not bearing a cell-specific
Introduction
Although many efforts have been made to develop nonviral gene delivery systems, [1] [2] [3] their transfection ability is still to be improved. Cationic liposomes are one of the most efficient nonviral systems and have been widely used. [4] [5] [6] [7] Cationic liposomes associate with DNA through electrostatic interactions and form complexes, which are termed lipoplexes. 8 While transfection activity of lipoplexes is shown to vary depending on their DNA/cationic lipid ratio, it is necessary for them to be positively charged to exhibit the transfection activity. Because cell surfaces are negatively charged, positively charged lipoplexes bind to cells. Felgner et al 7, 9 first proposed that DNA was transferred by direct fusion between the lipoplex and the plasma membrane. However, it is currently considered that an endocytic pathway is a major pathway for DNA entry into cells. 4, 10 Although there is some evidence which suggests that lipoplexes are able to destabilize and/or fuse with endosome, 11, 12 a large fraction of lipoplexes taken up by cells are considered to be trapped in endosome and eventually degraded in lysosome. 4, 13, 14 Accordingly, improvement of transfection efficiency of the lipoplexes can be expected by giving the lipoplexes some mechanism by which DNA ligand, transferrin, could transfect HeLa cells efficiently. In contrast, the negatively charged complexes hardly transfected the cells when transferrin was not conjugated to them. However, the negatively charged SucPG complexes bearing transferrin exhibited high transfection ability against HeLa and K562 cells, indicating that this gene delivery was achieved through their binding to the cellular receptors. These transferrin-attached, negatively charged complexes retained the high transfection ability in the presence of serum. Thus, this negatively charged complex may be useful as nonviral vectors in vivo. Gene Therapy (2001) 8, 5-12. can escape from the endosome, to lipoplexes. For this purpose, conjugation of pH-sensitive, membrane-active peptides, which destabilize endosomal membrane and induce disruption of the endosome, to lipoplexes has been attempted. [15] [16] [17] [18] Another approach to the promotion of DNA escape from endosome is to facilitate fusion between lipoplex and endosome. Previously, we have prepared liposomes modified with a pH-sensitive polyethylene glycol derivative, succinylated poly(glycidol) (SucPG) having n-decyl groups ( Figure 1 ) and shown that these liposomes become highly fusigenic under mildly acidic conditions. 19 Also, we found that the SucPG-modified liposomes deliver their contents into cytoplasm by fusing with endosome and/or lysosome. 20 Thus, we expected that complexation of these pH-sensitive, fusigenic liposomes with lipoplexes gives a novel gene delivery system which introduces DNA efficiently into cytoplasm by fusing with endosome and/or lysosome. In addition, if the lipoplex is fully covered with the SucPG-modified liposomes in the SucPG-modified liposome-lipoplex complexes, which are termed SucPG-complexes in this study, the complexes will possess negatively charged surfaces, which minimize nonspecific interaction with cells. Therefore, attachment of appropriate ligands to the complexes would provide systems with target cell-specificity. While various molecules have been used as target-specific ligands, 21 transferrin is one of the most attractive ligands, because expression of transferrin receptor is particularly high on proliferating malignant cells and transferrin bound to its receptor is internalized into the cell through an endocytic pathway. 22, 23 In this report, we demonstrate that complexation of transferrin-attached SucPG-modified liposomes with lipoplexes consisting of 3␤-(N-(NЈ,NЈ-dimethylaminoethane) carbamoyl)cholesterol (DC-chol), 24 DOPE and plasmid DNA gives a novel gene delivery system, which transfects target cells efficiently via the ligand-receptor interaction.
Results

Formation of SucPG-complex
The SucPG-complexes bearing transferrin were prepared by complexation of the SucPG-modified liposomes with a lipoplex consisting of DC-chol, DOPE and plasmid DNA, as schematically illustrated in Figure 2 . Transferrin is covalently conjugated to SucPG fixed on the liposome. Because the SucPG-modified liposome is negatively charged, it can associate with a positively charged lipoplex through electrostatic interaction to form a complex. In this study, the lipoplex with the DC-chol/nucleotide unit molar ratio of 2.0 was mixed with varying amounts of the SucPG-modified liposome bearing transferrin and incubated for 5 min to obtain the SucPG-complexes with varying succinylated unit/DC-chol molar ratios. Figure 3a represents the zeta potentials of particles existing in the mixed suspensions of the lipoplex and the SucPG-modified liposome. The lipoplex exhibited zeta potential of approximately 17 mV, indicating that the lipoplex is positively charged and this is consistent with its DC-chol/nucleotide unit molar ratio. However, when the SucPG-modified liposomes were mixed to the lipoplex suspension, particles existing in the suspension showed lower zeta potentials, depending on the amount of the SucPG-modified liposome added, suggesting that the lipoplex formed a complex with the SucPG-modified liposomes (SucPG-complex). When the succinylated unit/DC-chol molar ratio of the SucPG-complex was 0.5, zeta potential of the obtained complex was approximately 0 mV. Further increase in the succinylated unit/DC-chol ratio resulted in negative zeta potentials of the complex and reached a constant value of approximately −6 mV. Because this value corresponds to zeta potential of the transferrin-attached SucPG-modified liposome (−6.1 mV), the lipoplex is likely to be fully covered with this liposome in the SucPG-complexes with the succinylated unit/DC-chol molar ratios of 1-2.
The diameter of the SucPG-complex as a function of its succinylated unit/DC-chol ratio is shown in Figure 3b . While the SucPG-complex with the succinylated unit/DC-chol ratio of 0.5, which is a charge neutral complex, exhibited somewhat larger diameter, the complexes with other succinylated unit/DC-chol ratios, as well as the lipoplex showed similar diameters of approximately 700 nm.
The SucPG-modified liposomes formed the complex with the lipoplex via the electrostatic interaction. Therefore, formation of the SucPG-complex may cause dissociation of plasmid DNA from the lipoplex. To examine this, the SucPG-complexes with the succinylated unit/DC-chol ratios of 0-2 were electrophoresed in an agarose gel. However, free plasmid was not observed for these complexes, indicating that plasmid DNA was retained in the SucPG complexes of these compositions (result not shown).
Fusion ability of SucPG-complexes
We expected that when the SucPG-complex was internalized into a cell by endocytosis, the SucPG-modified liposomes bound to the lipoplex fuse with endosomal membrane as well as the lipoplex, resulting in transfer of DNA into the cytoplasm. Thus, we examined fusion between the SucPG-modified liposome and the lipoplex forming the SucPG-complex. The SucPG-complex was prepared by mixing the lipoplex containing NBD-PE and Rh-PE with the SucPG-modified liposomes and incubating for 5 min. The fluorescence intensity ratio of NBD-PE to Rh-PE (R) for the lipoplex was 0.31 before mixing with the SucPG liposomes. After the 5 min incubation with the SucPG-liposomes, the lipoplex showed approximately the same R value (0.32), indicating that fusion between the SucPG-modified liposome and the lipoplex did not occur during their complex formation. This result suggests that the SucPG-modified liposomes were bound to the lipoplex surface. Figure 4 depicts the time-course of percentage increase in the R of the SucPG-complex at varying pHs. The R hardly increased with time at pH 7.4. However, it increased gradually at pH 6.0 and more significantly at pH 5.0 with time, indicating that fusion between the SucPG-modified liposome and the lipoplex occurs in the SucPG-complex under weakly acidic conditions. We have already shown that fusion ability of the SucPG-modified liposomes increases with decreasing pH. 19 However, extent of the fusion was somewhat lower at pH 4.0 than at pH 5.0. Because a large part of the carboxyl groups on the SucPG were protonated at pH 4.0, 19 the Coulombic attraction between the SucPG-modified liposomes and the lipoplex should decrease. Thus, partial dissociation of the SucPG-modified liposomes from the lipoplex may take place at this pH, resulting in the lower extent of fusion.
Transfection mediated by the SucPG-complexes
We investigated transfection ability of the SucPGcomplexes containing plasmid p10, which contains 
Figure 4 Fusion between SucPG-modified liposome and lipoplex in transferrin-attached SucPG-complex at pHs 7.4 (˾), 6.0 (̄), 5.0 (©), and 4.0 (̆). Percentage increase in R as a function of time is shown.
luciferase coding sequence between Raus sarcoma virus LTR and polyadenylation signal. Figure 5 shows the luciferase activity of HeLa cells treated with the transferrin-attached or transferrin-free SucPG-complexes with varying succinylated unit/DC-chol ratios. In comparison with the lipoplex, the treatment with the transferrin-free SucPG-complex with the succinylated unit/DC-chol ratio of 0.25 induced a two-fold higher expression of luciferase in the cells. At this succinylated unit/DC-chol ratio, the SucPG-complex was positively charged (Figure 3) , and hence the complex could bind to the cell surface via electrostatic interaction. The complex internalized by the cell via endocytosis might release plasmid DNA more efficiently than the lipoplex, because the SucPG-modified liposome could mediate fusion of the lipoplex with the endosome. However, the SucPG-complexes with the succinylated unit/DC-chol ratio of higher than 0.5 exhibited much lower transfection activity. Because these complexes were neutral or negatively charged, their low Gene Therapy
Figure 5 Luciferase activity of HeLa cells treated with transferrinattached (˾) or transferrin-free (©) SucPG-complexes. The cells were treated with SucPG-complexes in the serum-free medium. Each point is the mean ± SD (n = 4).
activity might be due to the lack of affinity to the cell surface.
The cells treated with the transferrin-attached complex with the succinylated unit/DC-chol ratio of 0.25 expressed a 1.4-fold higher luciferase activity than the cells treated with the transferrin-free complex. This result suggests that transferrin attached to the positively charged complex can bind to its cellular receptor and enhance internalization of the complex by the cells. The transferrin-attached complex with the succinylated unit/DC-chol ratio of 0.5 exhibited lower activity than the complex with the succinylated unit/DC-chol ratio of 0.25 and this is consistent with the case of the transferrinfree complex. However, increase in the succinylated unit/DC-chol ratio to 1 resulted in an enhancement of the transfection activity. Although the complex of this composition has a negatively charged surface, this complex could bind to the cell through the ligand-receptor interaction. Because the complex with the succinylated unit/DC-chol ratio of 1 has more transferrin molecules than that with the ratio of 0.5, the former could be taken up by the cells more efficiently than the latter. The transferrin-attached complex with the succinylated unit/DCchol ratio of 2 exhibited only limited transfection ability. Probably, the transferrin-attached SucPG-modified liposomes, which did not form the SucPG-complex, coexisted in the sample of the SucPG-complex of this composition and these free transferrin-bearing liposomes might inhibit the binding of the SucPG-complex to the cellular receptor.
Transfection of K562 mediated by the SucPG-complexes and the plain lipoplex was also examined. The result is shown in Table 1 . As was the case of HeLa cells, the transferrin-attached SucPG-complex could, but the transferrin-free complex could not transfect K562 cells efficiently, suggesting that binding of transferrin and its receptor is crucial for the SucPG-complex-mediated transfection.
The effect of free transferrin on the SucPG-complexmediated transfection was further examined. HeLa cells were treated with the transferrin-attached SucPG-complex or the plain lipoplex in the absence or presence of free transferrin (10 m). To eliminate the influence of nonspecific adsorption of transferrin on to the lipoplex, 10% serum was included in the transfection medium. While the cells treated with the lipoplex either in the presence or absence of free transferrin exhibited approximately the same luciferase activity, the cells treated with the transferrin-attached SucPG-complex in the presence of free transferrin expressed 1/3 of the activity of the cells treated in the absence of transferrin (data not shown). This inhibition effect of free transferrin indicates that the SucPG-complex was taken up by the cell mainly through specific binding between transferrin and its receptor. Figure 6 represents luciferase activity of HeLa cells treated with either the SucPG-complex or the plain lipoplex in the presence of varying concentrations of serum. Serum-induced inhibition of lipoplex-mediated transfection has been often reported. [25] [26] [27] [28] However, the transfection ability of the SucPG-complex did not decrease even at a serum concentration of 40%. In contrast, the transfection activity of the plain lipoplex decreased slightly as serum concentration of the medium increased up to 20%, although its serum sensitivity was not significant.
Effect of serum
Transfection efficiency
HeLa cells were treated with either the SucPG-complex or the lipoplex containing pEGFP-C1, which encodes a red-shifted variant of wild-type green fluorescent protein. Succinylated unit/DC-chol ratio of the SucPG-complex was 1.
Figure 6 Effect of serum on transfection of HeLa cells mediated by transferrin-attached SucPG-complex (˾) and lipoplex (©). Succinylated unit/DC-chol ratio of SucPG complex was 1 (mol/mol). Each point is the mean ± SD (n = 4).
playing green fluorescence using a epifluorescence microscope. Figure 7 depicts percentage of the transfected cells by treatment with varying amounts of the SucPG-complex or the lipoplex in the absence or presence of serum. Although overlap of the error bars is seen within a given plasmid amount group, generally, the SucPG-complex transfected a somewhat larger fraction of the cells than 
Succinylated unit/DCchol ratio of SucPG complex was 1 (mol/mol). Each point is the mean ± SD (n = 4).
the plain lipoplex under the experimental conditions on the basis of the average. The transfection efficiency of 38% was achieved at maximum by the treatment with the SucPG-complex in the absence of serum. The transfection efficiency mediated by the SucPG-complex was elevated in the presence of 10% serum and reached approximately 44%.
Cytotoxicity
Cytotoxicities of the SucPG-complex and lipoplex containing plasmid p10 were examined by evaluating viability of HeLa cells treated with the complex or the plain lipoplex at varying concentrations of serum. Figure  8 shows the cell viability as a function of serum content during the cellular treatment. It is apparent that the SucPG-complex is less toxic than the plain lipoplex under experimental conditions. In addition, the cell viability was elevated with increasing serum content of the transfection medium. The cell viability was approximately 30%, when the cell was treated with the SucPG-complex in the serum-free medium. However, it was improved to be more than 60% by the treatment in the medium containing 40% serum, where the SucPG-complex exhibited high transfection ability ( Figure 6 ).
Discussion
Cationic liposomes were one of the most promising candidates for nonviral vectors. They associate with negatively charged DNA to form lipoplexes, which can bind to a cell surface via charge interaction and introduce DNA into the cell. However, they have several disadvantages. For example, their transfection ability is still inferior to viral vectors. Also, it is difficult to give them target specificity, because their affinity to the cell is based on nonspecific charge interaction.
In the present study, we attempted to solve these problems by combining the SucPG-modified liposome to a lipoplex of DC-chol, DOPE, and plasmid DNA. The SucPG-modified liposomes readily formed a complex,
Figure 8 Effect of serum on viability of HeLa cells treated with transferrin-attached SucPG-complex () and lipoplex (b). Viability was expressed as the percentage of the untreated control cells. Succinylated unit/DC-chol ratio of SucPG complex was 1 (mol/mol). Each point is the mean ± SD (n = 4).
Gene Therapy which is termed SucPG-complex, with the positively charged lipoplex without dissociation of plasmid DNA by mixing them together.
The SucPG-complexes with varying compositions were prepared by mixing the lipoplex with varying amounts of the SucPG-modified liposomes. The obtained complexes with a succinylated unit/DC-chol molar ratio less than 0.5 showed positive zeta potentials, whereas the complexes with a succinylated unit/DC-chol molar ratio more than 0.5 exhibited negative zeta potentials ( Figure  3a) . Because the lipoplex has the DC-chol/nucleotide molar ratio of 2/1, net charge of the SucPG complex with the succinylated unit/DC-chol molar ratio of 0.5 is zero and this is consistent with the result that the complex of this composition showed a zeta potential of 0 mV.
Since the lipoplex contains a lipid membrane structure, 29 some reorganization may occur during the SucPGcomplex formation via fusion. However, fusion assay by the resonance energy transfer method indicated that fusion does not occur during the SucPG-complex formation. In addition, except for the SucPG-complex with succinylated unit/DC-chol ratio of 0.5, which is a charge neutral complex, diameters of the SucPG-complexes with varying succinylated unit/DC-chol ratios and the plain lipoplex exhibited similar diameters (Figure 3b ), indicating that remarkable aggregation does not occur for these SucPG-complexes. On the basis of these results, it is likely that the SucPG-complexes have a structure in which the SucPG-modified liposomes are bound on the lipoplex.
While the SucPG-complex was stable at neutral pH, fusion of the SucPG-modified liposome and the lipoplex forming the SucPG-complex took place under weakly acidic conditions (Figure 4 ). This result indicates that fusion ability of the SucPG-complex increases under weakly acidic conditions and suggests that the complex can fuse with endosome and/or lysosome, which have weakly acidic environments.
Complexation of the SucPG-modified liposomes with the lipoplex was shown to increase its transfection ability, as long as the resultant SucPG-complexes had positively charged surface, even when the complex did not bear transferrin ( Figure 5 ). Many studies have shown that a variety of positively charged lipoplexes are taken up by cells through an endocytic pathway. 4, 10 Therefore, it is likely that the positively charged SucPG-complexes were internalized by endocytosis. The higher transfection ability of the SucPG-complex implies that the SucPGmodified liposomes bound to the lipoplex enhanced release of plasmid probably by fusion with endosome or lysosome. 20 In contrast, the SucPG-complexes with negatively charged surface hardly exhibited the transfection ability, if the complexes did not bear the ligand. Probably, the negatively charged complexes could not bind tightly to the cell surface, which is also negatively charged. However, the negatively charged complex bearing the ligand could transfect the cell effectively. This result suggests that the complex bound to the cellular receptor and was internalized via the receptor-mediated endocytosis. It was further confirmed by inhibition of the transferrinattached SucPG-complex-mediated transfection in the presence of free transferrin.
Yang and Huang 30 have shown that lipoplexes containing DC-chol become serum-resistant after a prolonged incubation for the lipoplex formation. Therefore, the plain lipoplex used in this study did not show a significant serum-sensitivity ( Figure 6 ). However, considering that many lipoplexes lose their transfection ability in the presence of serum, it is noteworthy that the transferrinattached SucPG-complex retained the high transfection ability in the presence of serum ( Figure 6 ). In contrast to the lipoplexes, which would interact with negatively charged serum proteins, the negatively charged SucPGcomplex hardly interacts with such proteins. Therefore, serum proteins did not prohibit its activity as strongly as they do against positively charged lipoplexes. In addition, the negatively charged SucPG-complex was shown to be less toxic to the cells than the plain lipoplex.
While negatively charged lipidic systems, such as pHsensitive liposomes, have several advantages, such as low cytotoxicity and targeting ability using cell-specific ligands, these have not been studied as extensively as positively charged lipoplexes for gene delivery purposes. Legendre and Szoka 31 reported that pH-sensitive liposomes are not as efficiently taken up by cells as DOTMA/DOPE/DNA lipoplex. However, conjugation of appropriate ligands to pH-sensitive liposomes can increase their affinity to the target cells. 32, 33 Another problem of negatively charged lipidic systems is their poor encapsulation efficiency against DNA due to its large size and negative charge. However, Lee and Huang 34 demonstrated that pH-sensitive liposomes encapsulating polylysine-condensed DNA can be obtained simply by mixing pH-sensitive liposomes bearing folate with polylysine-DNA complex and that the resultant liposomes are internalized via the receptormediated endocytosis and transfect KB cells efficiently. 34 Another approach to the preparation of negatively charged lipidic systems has been made by Dü zgü nes and coworkers, who prepared negatively charged ternary complexes of DNA, DOTAP/DOPE liposome and transferrin. 18, 35 They demonstrated that the ternary complexes transfected HeLa cells in the presence of serum, but percentage of the transfected cell by the treatment with the complex in the presence of 20% serum was 3-5%, as detected by expression of the ␤-galactosidase gene. 35 In this study, the SucPG-complex with negatively charged surface achieved higher transfection efficiency up to approximately 44% for the same cell line (Figure 7 ), although direct comparison was difficult due to the differences of plasmid, reporter gene, and transfection condition between these studies.
Concerning cytotoxicity, the SucPG-complex was shown to be less toxic than the plain lipoplex, probably because of their negatively charged surface. In addition, its cytotoxicity became weaker in the presence of serum (Figure 8 ). However, its cytotoxicity is still quite high and hence this is a subject for future study.
In conclusion, we demonstrated that complexation of the SucPG-modified liposomes with the lipoplex gave efficient gene delivery systems. The SucPG-complex with positively charged surface could transfect HeLa cells, regardless of the presence or absence of cell-specific ligand transferrin on the complex. The negatively charged SucPG-complex bearing transferrin introduced gene to the cells efficiently via specific binding between the ligand and its receptor on the cells. This transferrinattached, negatively charged complex exhibited high transfection ability in the presence of serum. In addition, its cytotoxicity was less than the plain lipoplex. Thus, this negatively charged complex and its future derivatives may be useful as nonviral vectors in vivo.
Materials and methods
Materials DOPE and egg yolk phosphatidylcholine were kindly donated by Nippon Oil and Fats Co (Tokyo, Japan). Human transferrin was supplied from Wako Pure Chemical Industries (Osaka, Japan). Fetal bovine serum (FBS) was from JRH Biosciences (Tokyo, Japan). DC-Chol was synthesized according to the method of Gao and Huang. 24 Succinylated poly(glycidol) having n-decyl groups (Figure 1 ) was synthesized according to the method previously reported. 20 Molar percentages of glycidol, succinylated glycidol, and n-decylamine-attached units in the resultant polymer was determined by 1 H-NMR to be 18, 74 and 8, respectively.
Preparation of SucPG-complexes
SucPG-modified liposomes were prepared from a mixture of SucPG and egg yolk phosphatidylcholine (3:7, w/w) as previously reported. 19, 20 The liposome suspension was extruded through a polycarbonate membrane with a pore size of 50 nm. To the liposome suspension was added 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (0.7 mg) at pH 6.0 and stirred for 2 h at 0°C. Then, transferrin (3 mg) was added to the liposome suspension and the suspension was kept at 4°C overnight. The liposome suspension was adjusted to pH 7.4 by adding 0.1 n NaOH and 0.5 m ferric citrate (5 l) was added to the suspension. The transferrin-conjugated SucPG-modified liposomes were purified using Sepharose 4B column at 4°C. Lipoplexes of DC-chol/DOPE liposomes and plasmid DNA were prepared according to the method of Gao and Huang. 36 A thin membrane of mixture of DC-chol (0.34 mg) and DOPE (0.6 mg) was prepared by evaporation of solution of these lipids in chloroform and subsequent drying under vacuum. The membrane was dispersed in PBS (5 ml) and sonicated for 2 min using a bath sonicator. Plasmid p10, which contains a firefly luciferase coding sequence derived from pGL3-basic (Promega, Madison, WI, USA) between Rous sarcoma virus LTR and polyadenylation signal, or pEGFP-C1 (Clontech, Palo Alto, CA, USA), which encodes a red-shifted variant of wild-type green fluorescent protein 37 (2 g) was dissolved in 20 mm Tris-HCl (100 l), added to the DCchol/DOPE liposome suspension (100 l) and incubated for 10 min in an ice bath to afford a lipoplex. To the lipoplex suspension was added a given volume (0-60 l) of suspension of SucPG-modified liposome either bearing or not bearing transferrin (0.3 mm) and incubated for 5 min in an ice bath.
Fusion assay
Fusion between SucPG-modified liposome and the lipoplex was detected by measuring resonance energy transfer between NBD-PE and Rh-PE. 38 Cationic liposome composed of DC-chol, DOPE, NBD-PE, and Rh-PE (44.5:54.3:0.6:0.6, mol/mol/mol/mol) was prepared following the above procedure. SucPG-complex was prepared using the labeled cationic liposome, plasmid DNA, and unlabeled SucPG-modified liposome according to the above method. Fluorescence intensity of NBD-PE and Rh-PE in the complex suspended in PBS of varying pHs was monitored using a RF-5000 spectrofluorometer (Shimadzu, Kyoto, Japan). Their fusion was followed by monitoring the fluorescence intensity ratio of NBD-PE to Rh-PE (R). 39, 40 The excitation wavelength for NBD-PE was 470 nm and monitoring wavelengths for NBD-PE and Rh-PE were 520 and 580 nm, respectively. Percentage increase in R was defined as:
where R 0 and R t represent the initial and intermediary R values. R 100 is the R value of the SucPG-complex when the cationic liposomes and the lipoplex in the SucPGcomplex fused completely. The SucPG-complex containing the labeled lipoplex was dissolved in methanol, dried by evaporation, and resuspended in PBS. The R value of the suspension was taken as R 100 .
Transfection
Transfection of cells was done according to the following procedures unless otherwise noted in the text. For transfection of HeLa cells, the cells were seeded in 1 ml of DMEM supplemented with 10% FBS in 24-well culture plates at 5 × 10 4 cells per well the day before transfection. The cells were washed with PBS and then covered with DMEM supplemented with 0-40% FBS (1 ml). The SucPG-complex or the lipoplex containing plasmid DNA (2 g) was added gently to the cells and incubated for 4 h at 37°C. Then, the cells were rinsed with PBS, covered with DMEM containing 10% FBS, and incubated at 37°C for 40 h. For transfection of K562 cells, the cells were seeded in 2 ml of RPMI1640 medium supplemented with 10% FBS in six-well culture plates at 2 × 10 5 cells per well the day before transfection. The cells were washed with PBS and suspended in the serum-free RPMI medium (1.5 ml). The SucPG-complex or the lipoplex containing plasmid DNA (4 g) was added to the cells and incubated for 4 h at 37°C. Then RPMI medium containing 20% FBS (1.5 ml) was added to the cell suspension without washing and incubated at 37°C for 40 h. For the luciferase assay, the cells were washed with PBS and lysed by adding 50 l of Luc-PGC-50 detergent (Toyo Ink, Tokyo, Japan). A 10 l aliquot from each dish was used for one luciferase assay using a kit (Toyo Ink) and a Lumat LB9507 luminometer (Berthold, Bad Wildbad, Germany). The protein content of the lysate was measured by BCA protein assay reagent (Pierce, IL, USA) using bovine serum albumin as the standard.
Cytotoxicity
Cytotoxicity was evaluated by cell viability. Cells (5 × 10 4 cells per well) were treated with the SucPG-complex or the lipoplex containing plasmid DNA (2 g) in DMEM containing varying concentrations of FBS for 4 h at 37°C, washed with PBS, and incubated in DMEM containing 10% FBS for 40 h at 37°C. As a control, cells without the above treatment were also incubated. Then, the cells were washed with PBS and lysed by adding 50 l of Luc-PGC-50 detergent. The cell number was evaluated from the protein concentration of the lysate using BCA protein assay. Viability was expressed as the percentage of the untreated control cells.
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Other methods
The phospholipid concentration was determined by an assay using Phospholipids B-Test Wako reagent supplied by Wako Pure Chemical Industries. The zeta potential and the size of liposomes, lipoplexes, and SucPG-complexes were measured using a Nicomp 380 ZLS instrument (Particle Sizing Systems, Santa Barbara, CA, USA).
